# Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

> **NCT00801632** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 5 (actual)

## Conditions studied

- Kidney Transplantation
- Kidney Failure, Chronic

## Interventions

- **PROCEDURE:** Kidney Transplantation
- **PROCEDURE:** Bone marrow transplantation
- **BIOLOGICAL:** MEDI-507
- **DRUG:** cyclophosphamide
- **BIOLOGICAL:** rituximab
- **DRUG:** Tacrolimus
- **DRUG:** corticosteroids
- **RADIATION:** thymic irradiation

## Key facts

- **NCT ID:** NCT00801632
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2014-04
- **Final completion:** 2014-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801632, "Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00801632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*